nialamide has been researched along with Hyperostosis Frontalis Interna in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Hyperostosis Frontalis Interna: Thickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FLOREZ TASCON, FJ | 1 |
1 other study available for nialamide and Hyperostosis Frontalis Interna
| Article | Year |
|---|---|
[Metabolic craneopathy and antidepressive therapeutics. (Neuroendocrine endocranial hyperostotic syndrome (N.E.H.S.) or Morgagni-Stewart-Morel-Pende syndrome and nialamide].
Topics: Depression; Humans; Hyperostosis Frontalis Interna; Iproniazid; Nialamide; Syndrome | 1960 |